Related Experiment Video
Updated: Sep 10, 2025

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
Non-coding RNAs regulate autophagy in kidney disease: friend or foe?
Yankun Li1, Tongtong Ma2, Xinhua Liang1
1Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Diseases of Zhanjiang City, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Non-coding RNAs offer a promising, tissue-specific approach to regulate autophagy in kidney disease, potentially avoiding side effects associated with traditional chemical treatments.
Area of Science:
- Cellular Biology
- Molecular Biology
- Nephrology
Background:
- Autophagy is crucial for kidney cell health, but its dysregulation (excessive or insufficient) is linked to kidney disease progression.
- Current chemical treatments for modulating autophagy can cause off-target side effects in other organs.
- Non-coding RNAs (ncRNAs) are tissue-specific molecules that can precisely regulate gene expression, including those involved in autophagy.
Purpose of the Study:
- To review the role of non-coding RNAs in modulating autophagy during kidney disease.
- To explore the therapeutic potential of ncRNAs for kidney disease treatment.
- To analyze evidence from in vitro, in vivo, and clinical studies.
Main Methods:
- Literature review and analysis of existing research on ncRNAs and kidney disease.
- Examination of studies investigating the impact of ncRNAs on autophagy pathways in kidney cells.
- Synthesis of findings from in vitro, in vivo, and clinical trial data.
Main Results:
- Non-coding RNAs demonstrate significant effects on autophagy regulation in the context of kidney disease.
- Dysregulated autophagy, influenced by ncRNAs, contributes to kidney disease pathogenesis.
- ncRNAs show potential for targeted therapeutic interventions with fewer systemic side effects.
Conclusions:
- Non-coding RNAs represent a novel and specific therapeutic avenue for managing kidney diseases by targeting autophagy.
- Further research into ncRNA-based therapies could lead to more effective and safer treatments for kidney disorders.
- Understanding ncRNA-mediated autophagy modulation is key to advancing nephrology therapeutics.
More Related Videos
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
09:10siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
lncRNA - Long Non-coding RNAs
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...